All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ALZAMEND NEURO, INC. Last Reported: 5/31/2024 Stock Symbol: ALZN

Business Address

3500 LENOX RD. NE
SUITE 1500
ATLANTA , GA US 30326

Mailing Address

3500 LENOX RD. NE
SUITE 1500
ATLANTA , GA US 30326
Phone Number: 844-722-6333 / State Incorporated: DE / Fiscal Year End 4 /30

Balance Sheet

Date 1/31/2024 10/31/2023 4/30/2023 1/31/2023 10/31/2022 4/30/2022 1/31/2022 10/31/2021 4/30/2021 1/31/2021 4/30/2020 4/30/2019 5/31/2016
Cash and Cash Equivalents $282,867.00 $200,079.00 $5,140,859.00 $7,375,841.00 $9,182,812.00 $14,063,811.00 $11,790,289.00 $13,572,692.00 $1,929,270.00 $40,737.00 $90,285.00 $42,606.00 --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $310,738.00 $581,802.00 $447,589.00 $546,303.00 $409,574.00 $349,723.00 $638,827.00 $928,204.00 $983,320.00 -- $1,622,815.00 -- --
Total Current Assets $593,605.00 $781,881.00 $5,835,782.00 $8,416,812.00 $10,334,387.00 $14,413,534.00 $12,429,116.00 $14,500,896.00 $2,912,590.00 -- $1,814,015.00 -- --
Property Plant and Equipement $189,031.00 $201,716.00 $79,843.00 $85,166.00 $90,489.00 $102,909.00 -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $782,636.00 $983,597.00 $5,915,625.00 $8,501,978.00 $10,424,876.00 $14,516,443.00 $12,429,116.00 $14,500,896.00 $2,912,590.00 -- $1,814,015.00 -- --
Accounts Payable $3,826,457.00 $3,666,090.00 $2,870,122.00 $2,642,473.00 $648,119.00 $1,162,850.00 $464,895.00 $1,128,410.00 $503,591.00 -- $929,639.00 -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $4,568,720.00 $3,666,090.00 $2,870,122.00 $2,642,473.00 $1,637,453.00 $1,164,932.00 -- -- -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-53,168,879.00 $-50,506,461.00 $-44,072,662.00 $-40,767,134.00 $-35,341,560.00 $-29,194,495.00 $-25,325,098.00 $-22,752,233.00 $-16,832,436.00 -- $-11,785,869.00 -- --
Total Stockholders' Equity $-4,263,821.00 $-2,682,493.00 $3,045,503.00 $5,859,505.00 $8,787,423.00 $13,351,511.00 $11,962,139.00 $13,025,411.00 $2,012,947.00 $-1,295,947.00 $821,709.00 $316,915.00 --
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $782,636.00 $983,597.00 $5,915,625.00 $8,501,978.00 $10,424,876.00 $14,516,443.00 $12,429,116.00 $14,500,896.00 $2,912,590.00 -- $1,814,015.00 -- --

Statement of Operations

Date 1/31/2024 10/31/2023 4/30/2023 1/31/2023 10/31/2022 4/30/2022 1/31/2022 10/31/2021 4/30/2021 1/31/2021 4/30/2020 4/30/2019 5/31/2016
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $6,271,677.00 $4,362,920.00 $7,445,857.00 $5,797,789.00 $1,532,985.00 $5,201,314.00 $873,653.00 $1,750,050.00 $1,310,716.00 $234,262.00 $1,069,418.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $9,087,581.00 $6,427,652.00 -- -- -- -- -- -- -- -- -- -- --
Loss from Operations $-2,659,930.00 $-6,427,652.00 $-14,870,466.00 $-11,565,457.00 $-6,141,945.00 $-12,319,535.00 $-8,446,739.00 $-5,890,173.00 $-4,951,888.00 $-1,115,659.00 $-4,424,161.00 -- --
Loss Before Income Taxes -- -- $-14,878,167.00 -- -- $-12,362,059.00 -- -- $-5,046,567.00 -- $-4,410,236.00 -- --
Earnings Per Share Basic $-1.35 $-0.98 $-0.15 $-0.12 $-0.06 -- -- -- -- -- -- -- --
Weighted Average Shares Basic 6,726,926 6,563,230 97,519,016 -- -- 89,095,274 -- -- -- -- -- -- --
Earnings Per Share Diluted $-1.35 $-0.98 $-0.15 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 6,726,926 6,563,230 97,519,016 97,765,471 97,488,448 -- -- -- -- -- -- -- --
Common Stock Shares Authorized 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 -- 300,000,000 -- 300,000,000
Common Stock Shares Outstanding 6,618,766 6,469,657 96,940,124 96,427,624 95,494,290 95,481,790 -- -- 67,429,525 -- 64,762,858 -- --
Common Stock Value $662.00 $647.00 $9,694.00 $9,642.00 $9,549.00 $9,548.00 $9,010.00 $8,885.00 $6,743.00 -- $6,476.00 -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- 10,000,000 -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- $75.00 -- $75.00 -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com